Bluesky Facebook Reddit Email

GLP-1s may alleviate depression in mice through the microbiome

06.10.26 | Cell Press

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Some people taking GLP-1 drugs for diabetes and obesity experience mental health benefits—particularly, a decrease in symptoms of depression. In a mouse model study in the Cell Press journal Cell Host & Microbe publishing on June 10, researchers report that these mental health improvements appear to result from changes in the gut microbiome that lead to an abundance of a microbe strain known to have a favorable effect on neurons related to stress.

“Previous clinical and preclinical studies have been contradictory,” says co-corresponding author Yonggui Yuan of Southeast University in Jiangsu, China. “Some studies reported antidepressant effects of GLP-1 agonists, while others suggested increased risk of depression or anxiety. The prevailing model held that these drugs act directly on GLP-1 receptors in the brain, while our study provides evidence for an alternative pathway.”

For this study, the researchers used the weight-loss drug liraglutide, marketed under the brand names Victoza and Saxenda. To determine the drug’s effect on the brain, the team mimicked stress in mouse models. “We observed that when we systemically administered liraglutide to the mice, it accumulated predominantly in the intestine rather than the brain,” says co-corresponding author Bing Han, also of Southeast University.

Using standard behavioral tests, the researchers showed that liraglutide retained its antidepressant activity even in mice with GLP-1 receptors knocked out. This suggested the effects came about through another pathway.

The team then showed that mice whose gut microbiota had been depleted using broad-spectrum antibiotics did not experience liraglutide’s antidepressant effects, pointing to a key role for the microorganisms in the gut.

To identify specific microbial taxa involved, the team studied fecal samples from the mice. Among the microorganisms altered by liraglutide, Lactobacillus delbrueckii was the most significantly increased species. L. delbrueckii produces diacylglycerol—a precursor that is converted into the endocannabinoid 2-arachidonoylglycerol (2-AG). Elevated 2-AG is known to normalize hyperactivation in stress-related brain regions.

“We found that the abundance of L. delbrueckii correlated with behavioral improvements,” says co-corresponding author Honghong Yao, also of Southeast University.

This finding revealed a brain-gut microbiota connection that directly links metabolic drugs such as liraglutide to mood regulation.

The researchers say the finding suggests several potential clinical applications, including treating patients with metabolic conditions such as diabetes and obesity who are also experiencing depression and targeting depression through probiotic intervention.

They also note several limitations to the work, including the fact that it was done in mouse models, not humans, and that the mice were all male. Because depression is different in males and females, it’s important to determine whether the mechanisms are the same in both sexes, says the team.

###

This work was supported by grants from the Science and Technology Innovation 2030-Major Project of the Ministry of Science and Technology of China, the National Natural Science Foundation of Distinguished Young Scholars, the National Natural Science Foundation of China, the Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China, the Major Science and Technology Projects in Jiangsu Province, the Natural Science Foundation Outstanding Youth Fund of Jiangsu Province, the Fundamental Research Funds for the Central Universities, the Jiangsu Province High-Level Hospital Construction Funds of Zhongda Hospital, School of Medicine, Southeast University, and the Nanjing U35 Strong Foundation Program.

Cell Host & Microbe , Bian et al., “Microbiota-driven gut-brain signaling underlies antidepressant effects of a GLP-1 analog” https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(26)00179-4

Cell Host & Microbe ( @cellhostmicrobe ), published by Cell Press, is a monthly journal that publishes novel findings and translational studies related to microbes (which include bacteria, fungi, parasites, and viruses). The unifying theme is the integrated study of microbes in conjunction and communication with each other, their host, and the cellular environment they inhabit. Visit http://www.cell.com/cell-host-microbe . To receive Cell Press media alerts, contact press@cell.com .

Cell Host & Microbe

10.1016/j.chom.2026.05.003

Experimental study

Animals

Microbiota-driven gut–brain signaling underlies antidepressant effects of a GLP-1 analog

10-Jun-2026

Keywords

Article Information

Contact Information

Julia Grimmett
Cell Press
press@cell.com

How to Cite This Article

APA:
Cell Press. (2026, June 10). GLP-1s may alleviate depression in mice through the microbiome. Brightsurf News. https://www.brightsurf.com/news/80ED2VQ8/glp-1s-may-alleviate-depression-in-mice-through-the-microbiome.html
MLA:
"GLP-1s may alleviate depression in mice through the microbiome." Brightsurf News, Jun. 10 2026, https://www.brightsurf.com/news/80ED2VQ8/glp-1s-may-alleviate-depression-in-mice-through-the-microbiome.html.